{
  "main_header": {
    "sid": 213056,
    "name": "Sequent Scien.",
    "stock_name": "Sequent Scien.",
    "full_name": "Sequent Scientific Ltd",
    "name_url": "stocks-analysis/sequent-scien",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "210.80",
    "chg": 1.55,
    "chgp": "0.74%",
    "dir": 1,
    "prev_price": "209.25",
    "mcapval": "5,383.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 512529,
    "symbol": "SEQUENT",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE807F01027",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "6.34 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sequent-scien-213056-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://www.marketsmojo.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sequent-scien-213056-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Sequent Scien. Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sequent-scien-upgraded-from-sell-to-hold-by-marketsmojo-on-2-sep-2025-3763699",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SequentScien_mojoScore_3763699.png",
        "date": "2025-12-19 10:10:34",
        "description": "Sequent Scien., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This adjustment follows a period marked by contrasting performance indicators across quality, valuation, financial trends, and technical parameters."
      },
      {
        "title": "Why is Sequent Scien. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sequent-scien-fallingrising-3757709",
        "imagepath": "",
        "date": "2025-12-13 00:59:31",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Outperformance</strong></p>\n<p>Sequent Scientific’s shares have demonstrated notable resilience and strength in recent trading sessions. Over the past week, the stock has gained 5.08%, significantly outperforming the Sensex, which declined by 0.52% during the same period. This upward momentum has continued into the last two days, with the stock delivering a 4.46% return in that short span. On 12-Dec, the stock touched an intraday high of ₹210.85, marking a 2.45% increase from its previous close. Such performance indicates positive market sentiment towards the company, especially when compared to its sector peers where it outperformed by 1.89% on the day.</p>\n<p><strong>Strong Financial Performance Underpinning the Rally</strong></p>\n<p>The primary catalyst be..."
      },
      {
        "title": "Sequent Scientific Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sequent-scientific-technical-momentum-shifts-amid-mixed-market-signals-3742737",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SequentScientif_technicaldot_3742737.png",
        "date": "2025-12-03 08:01:54",
        "description": "Sequent Scientific, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent evaluation adjustments highlight a transition from a strongly bullish stance to a more tempered mildly bullish outlook, underscoring the importance of closely monitoring technical indicators such as MACD, RSI, moving averages, and other momentum oscillators."
      },
      {
        "title": "Is Sequent Scien. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-sequent-scien-overvalued-or-undervalued-3739814",
        "imagepath": "",
        "date": "2025-12-02 08:08:12",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Understanding Sequent Scientific’s Valuation Metrics</strong></p>\n<p>Sequent Scientific currently trades at a price of ₹221.25, having seen a 52-week range between ₹111.00 and ₹260.30. The company’s price-to-earnings (PE) ratio stands at a striking 126.16, which is considerably higher than typical industry averages. This elevated PE ratio often signals high growth expectations priced into the stock. However, the price-to-book value of 6.92 and enterprise value to EBITDA (EV/EBITDA) ratio of 31.90 indicate that while the stock is priced richly, it is not excessively so when compared to its earnings before interest, taxes, depreciation, and amortisation.</p>\n<p>Return on capital employed (ROCE) at 10.17% and return on equity (ROE) at 5.48% reflect moderate profitability levels. These returns, ..."
      },
      {
        "title": "Sequent Scien. Sees Revision in Market Assessment Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sequent-scien-upgraded-from-sell-to-hold-by-marketsmojo-on-2-sep-2025-3735288",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SequentScien_mojoScore_3735288.png",
        "date": "2025-11-28 10:04:56",
        "description": "Sequent Scien., a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a revision in its market evaluation. This shift reflects a nuanced view of the company’s financial and technical parameters, highlighting both promising trends and ongoing challenges within its operational and valuation metrics."
      },
      {
        "title": "Sequent Scientific Hits Intraday Low Amid Price Pressure and Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sequent-scientific-hits-intraday-low-amid-price-pressure-on-24-nov-2025-3725847",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SequentScientif_priceRelatedfactors_3725847.png",
        "date": "2025-11-24 15:15:53",
        "description": "Sequent Scientific experienced notable intraday weakness on 24 Nov 2025, touching a low of Rs 221.1 as the stock faced significant price pressure. The decline occurred amid broader market volatility, with the Sensex reversing sharply after a positive start to the day."
      },
      {
        "title": "Sequent Scientific Hits Intraday Low Amid Price Pressure and Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sequent-scientific-hits-intraday-low-amid-price-pressure-on-20-nov-2025-3718476",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SequentScientif_priceRelatedfactors_3718476.png",
        "date": "2025-11-20 15:46:24",
        "description": "Sequent Scientific experienced a notable intraday decline on 20 Nov 2025, touching a low of Rs 234, reflecting a price pressure of 7.12% during the trading session. This movement contrasts with the broader market trend, where the Sensex recorded gains and reached a new 52-week high."
      },
      {
        "title": "Sequent Scientific Hits New 52-Week High at Rs.260.3 Mark",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sequent-scientific-hits-new-52-week-high-at-rs2603-3714985",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SequentScientif_priceRelatedfactors_3714985.png",
        "date": "2025-11-19 09:43:59",
        "description": "Sequent Scientific, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.260.3 today, marking a significant milestone in its stock performance. This peak reflects the stock’s sustained momentum over the past year amid a broader market environment showing cautious optimism."
      },
      {
        "title": "Why is Sequent Scien. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sequent-scien-fallingrising-3712855",
        "imagepath": "",
        "date": "2025-11-18 21:51:52",
        "description": "As of 18-Nov, Sequent Scientific Ltd is experiencing a price increase, currently at Rs. 247.65, reflecting a rise of 16.3 points or 7.05%. The stock has recently hit a new 52-week high of Rs. 249.5 and has shown strong performance today, outperforming its sector by 7.67%. Over the past week, the stock has gained 8.29%, and it has delivered a remarkable 22.03% return over the last month. The company has reported a significant growth in net profit of 209.15% and has declared positive results for the last seven consecutive quarters, contributing to investor confidence. Additionally, the stock's moving averages indicate it is trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day averages, suggesting a strong upward trend.\n\nIn the broader market context, Sequent Scientific's short-term performance has significantly outpaced the benchmark, with a 1-week return of 8.29% compared to the Sensex's 0.96%..."
      }
    ],
    "total": 218,
    "sid": "213056",
    "stock_news_url": "https://www.marketsmojo.com/news/sequent-scientific-213056"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011",
      "datetime": "17-Dec-2025",
      "details": "The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for CA Hull Investments & PAC",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "17-Dec-2025",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for CA Hull Investments & PAC",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
      "datetime": "17-Dec-2025",
      "details": "The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for CA Hull Investments & PAC",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sequent Scientific Ltd has declared <strong>25%</strong> dividend, ex-date: 08 Sep 21",
          "dt": "2021-09-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sequent Scientific Ltd has announced <strong>2:10</strong> stock split, ex-date: 25 Feb 16",
          "dt": "2016-02-25",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sequent Scien. Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-12-19 10:10:34

Sequent Scien., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This adjustment follows a period marked by contrasting performance indicators across quality, valuation, financial trends, and technical parameters.

Read More

Why is Sequent Scien. falling/rising?

2025-12-13 00:59:31

Recent Price Movement and Market Outperformance

Sequent Scientific’s shares have demonstrated notable resilience and strength in recent trading sessions. Over the past week, the stock has gained 5.08%, significantly outperforming the Sensex, which declined by 0.52% during the same period. This upward momentum has continued into the last two days, with the stock delivering a 4.46% return in that short span. On 12-Dec, the stock touched an intraday high of ₹210.85, marking a 2.45% increase from its previous close. Such performance indicates positive market sentiment towards the company, especially when compared to its sector peers where it outperformed by 1.89% on the day.

Strong Financial Performance Underpinning the Rally

The primary catalyst be...

Read More

Sequent Scientific Technical Momentum Shifts Amid Mixed Market Signals

2025-12-03 08:01:54

Sequent Scientific, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent evaluation adjustments highlight a transition from a strongly bullish stance to a more tempered mildly bullish outlook, underscoring the importance of closely monitoring technical indicators such as MACD, RSI, moving averages, and other momentum oscillators.

Read More

Is Sequent Scien. overvalued or undervalued?

2025-12-02 08:08:12

Understanding Sequent Scientific’s Valuation Metrics

Sequent Scientific currently trades at a price of ₹221.25, having seen a 52-week range between ₹111.00 and ₹260.30. The company’s price-to-earnings (PE) ratio stands at a striking 126.16, which is considerably higher than typical industry averages. This elevated PE ratio often signals high growth expectations priced into the stock. However, the price-to-book value of 6.92 and enterprise value to EBITDA (EV/EBITDA) ratio of 31.90 indicate that while the stock is priced richly, it is not excessively so when compared to its earnings before interest, taxes, depreciation, and amortisation.

Return on capital employed (ROCE) at 10.17% and return on equity (ROE) at 5.48% reflect moderate profitability levels. These returns, ...

Read More

Sequent Scien. Sees Revision in Market Assessment Amid Mixed Financial Signals

2025-11-28 10:04:56

Sequent Scien., a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a revision in its market evaluation. This shift reflects a nuanced view of the company’s financial and technical parameters, highlighting both promising trends and ongoing challenges within its operational and valuation metrics.

Read More

Sequent Scientific Hits Intraday Low Amid Price Pressure and Market Volatility

2025-11-24 15:15:53

Sequent Scientific experienced notable intraday weakness on 24 Nov 2025, touching a low of Rs 221.1 as the stock faced significant price pressure. The decline occurred amid broader market volatility, with the Sensex reversing sharply after a positive start to the day.

Read More

Sequent Scientific Hits Intraday Low Amid Price Pressure and Market Sentiment

2025-11-20 15:46:24

Sequent Scientific experienced a notable intraday decline on 20 Nov 2025, touching a low of Rs 234, reflecting a price pressure of 7.12% during the trading session. This movement contrasts with the broader market trend, where the Sensex recorded gains and reached a new 52-week high.

Read More

Sequent Scientific Hits New 52-Week High at Rs.260.3 Mark

2025-11-19 09:43:59

Sequent Scientific, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.260.3 today, marking a significant milestone in its stock performance. This peak reflects the stock’s sustained momentum over the past year amid a broader market environment showing cautious optimism.

Read More

Why is Sequent Scien. falling/rising?

2025-11-18 21:51:52

As of 18-Nov, Sequent Scientific Ltd is experiencing a price increase, currently at Rs. 247.65, reflecting a rise of 16.3 points or 7.05%. The stock has recently hit a new 52-week high of Rs. 249.5 and has shown strong performance today, outperforming its sector by 7.67%. Over the past week, the stock has gained 8.29%, and it has delivered a remarkable 22.03% return over the last month. The company has reported a significant growth in net profit of 209.15% and has declared positive results for the last seven consecutive quarters, contributing to investor confidence. Additionally, the stock's moving averages indicate it is trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day averages, suggesting a strong upward trend. In the broader market context, Sequent Scientific's short-term performance has significantly outpaced the benchmark, with a 1-week return of 8.29% compared to the Sensex's 0.96%...

Read More

View All News